1
|
Liu Y, Chai YH, Wu YF, Zhang YW, Wang L, Yang L, Shi YH, Wang LL, Zhang LS, Chen Y, Fan R, Wen YH, Yang H, Li L, Liu YH, Zheng HZ, Jiang JJ, Qian H, Tao RJ, Qian YC, Wang LW, Chen RC, Xu JF, Wang C. Risk factors associated with indoor transmission during home quarantine of COVID-19 patients. Front Public Health 2023; 11:1170085. [PMID: 37250088 PMCID: PMC10213781 DOI: 10.3389/fpubh.2023.1170085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2023] [Accepted: 04/13/2023] [Indexed: 05/31/2023] Open
Abstract
Purpose The study aimed to identify potential risk factors for family transmission and to provide precautionary guidelines for the general public during novel Coronavirus disease 2019 (COVID-19) waves. Methods A retrospective cohort study with numerous COVID-19 patients recruited was conducted in Shanghai. Epidemiological data including transmission details, demographics, vaccination status, symptoms, comorbidities, antigen test, living environment, residential ventilation, disinfection and medical treatment of each participant were collected and risk factors for family transmission were determined. Results A total of 2,334 COVID-19 patients participated. Compared with non-cohabitation infected patients, cohabitated ones were younger (p = 0.019), more commonly unvaccinated (p = 0.048) or exposed to infections (p < 0.001), and had higher rates of symptoms (p = 0.003) or shared living room (p < 0.001). Risk factors analysis showed that the 2019-nCov antigen positive (OR = 1.86, 95%CI 1.40-2.48, p < 0.001), symptoms development (OR = 1.86, 95%CI 1.34-2.58, p < 0.001), direct contact exposure (OR = 1.47, 95%CI 1.09-1.96, p = 0.010) were independent risk factors for the cohabitant transmission of COVID-19, and a separate room with a separate toilet could reduce the risk of family transmission (OR = 0.62, 95%CI 0.41-0.92, p = 0.018). Conclusion Patients showing negative 2019-nCov antigen tests, being asymptomatic, living in a separate room with a separate toilet, or actively avoiding direct contact with cohabitants were at low risk of family transmission, and the study recommended that avoiding direct contact and residential disinfection could reduce the risk of all cohabitants within the same house being infected with COVID-19.
Collapse
Affiliation(s)
- Yang Liu
- Institute of Respiratory Medicine, School of Medicine, Tongji University, Shanghai, China
| | - Yan-Hua Chai
- Institute of Respiratory Medicine, School of Medicine, Tongji University, Shanghai, China
| | - Yi-Fan Wu
- Institute of Respiratory Medicine, School of Medicine, Tongji University, Shanghai, China
| | - Yu-Wei Zhang
- Institute of Respiratory Medicine, School of Medicine, Tongji University, Shanghai, China
| | - Ling Wang
- Institute of Respiratory Medicine, School of Medicine, Tongji University, Shanghai, China
| | - Ling Yang
- Institute of Respiratory Medicine, School of Medicine, Tongji University, Shanghai, China
| | - Yi-Han Shi
- Institute of Respiratory Medicine, School of Medicine, Tongji University, Shanghai, China
| | - Le-Le Wang
- Institute of Respiratory Medicine, School of Medicine, Tongji University, Shanghai, China
| | - Li-Sha Zhang
- Institute of Respiratory Medicine, School of Medicine, Tongji University, Shanghai, China
| | - Yan Chen
- Institute of Respiratory Medicine, School of Medicine, Tongji University, Shanghai, China
| | - Rui Fan
- Institute of Respiratory Medicine, School of Medicine, Tongji University, Shanghai, China
| | - Yu-Hua Wen
- Institute of Respiratory Medicine, School of Medicine, Tongji University, Shanghai, China
| | - Heng Yang
- Institute of Respiratory Medicine, School of Medicine, Tongji University, Shanghai, China
| | - Li Li
- Department of Respiratory Medicine, Baoshan District Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China
| | - Yi-Han Liu
- Institute of Respiratory Medicine, School of Medicine, Tongji University, Shanghai, China
| | - Hui-Zhen Zheng
- Institute of Respiratory Medicine, School of Medicine, Tongji University, Shanghai, China
| | - Ji-Jin Jiang
- Institute of Respiratory Medicine, School of Medicine, Tongji University, Shanghai, China
| | - Hao Qian
- Institute of Respiratory Medicine, School of Medicine, Tongji University, Shanghai, China
| | - Ru-Jia Tao
- Institute of Respiratory Medicine, School of Medicine, Tongji University, Shanghai, China
| | - Ye-Chang Qian
- Department of Respiratory Medicine, Baoshan District Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China
| | - Ling-Wei Wang
- Shenzhen Institute of Respiratory Disease, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China
- Shenzhen Clinical Research Centre for Respirology, Shenzhen People’s Hospital, Shenzhen, China
| | - Rong-Chang Chen
- Shenzhen Institute of Respiratory Disease, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China
- Shenzhen Clinical Research Centre for Respirology, Shenzhen People’s Hospital, Shenzhen, China
| | - Jin-Fu Xu
- Institute of Respiratory Medicine, School of Medicine, Tongji University, Shanghai, China
| | - Chen Wang
- National Center for Respiratory Medicine, Beijing, China
- National Clinical Research Center for Respiratory Disease, Beijing, China
- Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
| |
Collapse
|
3
|
Kanda E, Suzuki A, Makino M, Tsubota H, Kanemata S, Shirakawa K, Yajima T. Machine learning models for prediction of HF and CKD development in early-stage type 2 diabetes patients. Sci Rep 2022; 12:20012. [PMID: 36411366 PMCID: PMC9678863 DOI: 10.1038/s41598-022-24562-2] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2022] [Accepted: 11/17/2022] [Indexed: 11/23/2022] Open
Abstract
Chronic kidney disease (CKD) and heart failure (HF) are the first and most frequent comorbidities associated with mortality risks in early-stage type 2 diabetes mellitus (T2DM). However, efficient screening and risk assessment strategies for identifying T2DM patients at high risk of developing CKD and/or HF (CKD/HF) remains to be established. This study aimed to generate a novel machine learning (ML) model to predict the risk of developing CKD/HF in early-stage T2DM patients. The models were derived from a retrospective cohort of 217,054 T2DM patients without a history of cardiovascular and renal diseases extracted from a Japanese claims database. Among algorithms used for the ML, extreme gradient boosting exhibited the best performance for CKD/HF diagnosis and hospitalization after internal validation and was further validated using another dataset including 16,822 patients. In the external validation, 5-years prediction area under the receiver operating characteristic curves for CKD/HF diagnosis and hospitalization were 0.718 and 0.837, respectively. In Kaplan-Meier curves analysis, patients predicted to be at high risk showed significant increase in CKD/HF diagnosis and hospitalization compared with those at low risk. Thus, the developed model predicted the risk of developing CKD/HF in T2DM patients with reasonable probability in the external validation cohort. Clinical approach identifying T2DM at high risk of developing CKD/HF using ML models may contribute to improved prognosis by promoting early diagnosis and intervention.
Collapse
Affiliation(s)
- Eiichiro Kanda
- grid.415086.e0000 0001 1014 2000Medical Science, Kawasaki Medical University, Okayama, Japan
| | - Atsushi Suzuki
- grid.256115.40000 0004 1761 798XDepartment of Endocrinology, Diabetes and Metabolism, Fujita Health University, Toyoake, Aichi Japan
| | - Masaki Makino
- grid.256115.40000 0004 1761 798XDepartment of Endocrinology, Diabetes and Metabolism, Fujita Health University, Toyoake, Aichi Japan
| | - Hiroo Tsubota
- grid.476017.30000 0004 0376 5631AstraZeneca K.K., Osaka, Japan
| | - Satomi Kanemata
- grid.459873.40000 0004 0376 2510Ono Pharmaceutical Co., Ltd., Osaka, Japan
| | | | | |
Collapse
|